Pozen

Elizabeth A. Cermak has been named executive vice president, chief commercial officer of Pozen, Inc. Ms. Cermak will be responsible for the development and implementation of Pozen’s commercialization strategy for all of its future product candidates.

Ms. Cermak was employed for 25 years at Johnson & Johnson, where she held positions of increasing responsibility at Ortho-McNeil Pharmaceuticals, McNeil Consumer and Specialty Pharmaceuticals and other Johnson and Johnson subsidiaries. She most recently held the position of world-wide vice president Personal Products Franchise, Johnson & Johnson Healthcare Products. Her experience spans both prescription and OTC businesses across many therapeutic areas. She specialized in sales and marketing and has managed large and small business units both domestically and outside the U.S.

Pozen previously announced its intention to retain sole ownership of its PA franchise of product candidates while it advances them through Phase III and considers how best to commercialize these assets. Ms. Cermak will be responsible for the development of worldwide commercial strategy for these product candidates. She will also be responsible for the management of all current and future strategic alliances for the Pozen portfolio, as well as business development.

Dr. John R. Plachetka, Pozen’s chairman, president and chief executive officer, said, “Hiring an outstanding, multi-talented pharma executive like Liz is a key step in Pozen’s evolution as a company. She has precisely the right experiences and background to help us determine how best we can maximize the value of our PA assets around the world, and all our other products and product candidates, for our shareholders.”